The Pathologist / Issues / 2026 / June / Beating Tissue Failure in Oncology
Histology Precision medicine Bioinformatics Digital and computational pathology Screening and monitoring Software and hardware Technology and innovation Digital Pathology

Beating Tissue Failure in Oncology

A patented AI platform trained on NYU Langone research is predicting cancer mutations from haematoxylin and eosin alone — closing the gap for the 25 percent of patients who never reach molecular testing

By Helen Bristow 06/04/2026 Interview 5 min read

Share

Objective:

Revise to directly reference the challenges in oncology as mentioned in the source.

Key Findings:
  • Add source attribution for each finding.
Interpretation:

Remove or rephrase to eliminate unsupported editorial interpretation.

Limitations:
  • Add source attribution for each limitation.
Conclusion:

Remove or rephrase to eliminate unsupported forward-looking statements.

About the Author(s)

Helen Bristow

Combining my dual backgrounds in science and communications to bring you compelling content in your speciality.

More Articles by Helen Bristow

Explore More in Pathology

Dive deeper into the world of pathology. Explore the latest articles, case studies, expert insights, and groundbreaking research.

Recommended